Tern PLC on Tuesday announced that one of its investee company’s had a strong start to the year.
The London-based ’internet of things’ technology investor owns a 24% stake in healthcare intelligence company Talking Medicines Ltd.
Talking Medicines, an industry pioneer leveraging advanced data science and artificial intelligence, reported record revenue bookings in the first quarter of 2024.
The company also made improvements to its Drug-GPT platform which aims to revolutionise access to intelligence on diseases and pharmaceutical brands.
Talking Medicines said: ‘This innovative technology has garnered substantial interest from leading global healthcare advertising agencies, who recognise its potential to transform strategies for pharmaceutical clients.’
Looking ahead, Talking Medicines stated that it remains committed to driving innovation and improving healthcare decision making.
Tern shares were up 14% to 3.54 pence each in London on Tuesday morning.
Copyright 2024 Alliance News Ltd. All Rights Reserved.
